InvestorsHub Logo
Replies to #303 on Deltagen (DGEN)

finbar99

10/01/10 3:17 PM

#304 RE: finbar99 #303

I do believe that certain royalty rights with the big pharmas who were subscribers were waived as part of the bk exit process - in exchange for releases on deliveries of new knockout lines - but there remains potential over and above what Benten can do.